|
1）Maehata Y, Esaki M, Morishita T, et al. Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam. J Gastroenterol. 2012; 47: 387-93
|
|
|
|
2）Iwamoto J, Mizokami Y, Saito Y, et al. Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding. World J Gastroenterol. 2014; 20: 13133-8
|
|
|
|
|
|
3）Shi S, Wang H, Gao H, et al. Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laser endomicroscopy in indomethacin-induced enteropathy. Dig Dis Sci. 2014; 59: 1398-405
|
|
|
|
|
|
4）Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011; 141: 1314-22, 22.e1-5
|
|
|
|
|
|
5）Satoh H, Amagase K, Takeuchi K. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. J Pharmacol Exp Ther. 2012; 343: 270-7
|
|
|
|
|
|
6）Nadatani Y, Watanabe T, Tanigawa T, et al. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4. Am J Pathol. 2012; 181: 98-110
|
|
|
|
|
|
7）Gyenge M, Amagase K, Kunimi S, et al. Roles of pro-angiogenic and anti-angiogenic factors as well as matrix metalloproteinases in healing of NSAID-induced small intestinal ulcers in rats. Life Sci. 2013; 93: 441-7
|
|
|
|
|
|
8）LoGuidice A, Wallace BD, Bendel L, et al. Pharmacologic targeting of bacterial beta-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J Pharmacol Exp Ther. 2012; 341: 447-54
|
|
|
|
|
|
9）Zhu Y, Zhang QY. Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine. J Pharmacol Exp Ther. 2012; 343: 362-70
|
|
|
|
|
|
10）Yamawaki H, Mihara H, Suzuki N, et al. Role of transient receptor potential vanilloid 4 activation in indomethacin-induced intestinal damage. Am J Physiol Gastrointest Liver Physiol. 2014; 307: G33-40
|
|
|
|
|
|
11）Kato S, Matsuda N, Matsumoto K, et al. Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors. Pharmacol Res. 2012; 66: 226-34
|
|
|
|
|
|
12）Satoh H, Amagase K, Takeuchi K. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats. J Pharmacol Exp Ther. 2014; 348: 227-35
|
|
|
|
|
|
13）Nagano Y, Matsui H, Shimokawa O, et al. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells. J Physiol Pharmacol. 2012; 63: 137-42
|
|
|
|
|
|
14）Kurokawa S, Katsuki S, Fujita T, et al. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury. J Gastroenterol. 2014; 49: 239-44
|
|
|
|
|
|
15）Mizukami K, Murakami K, Abe T, et al. Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol. 2011; 17: 5117-22
|
|
|
|
|
|
16）Kuramoto T, Umegaki E, Nouda S, et al. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study. BMC Gastroenterol. 2013; 13: 85
|
|
|
|
|
|
17）Isomura Y, Yamaji Y, Yamada A, et al. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs. Gastrointest Endosc. 2014; 80: 118-25
|
|
|
|
|
|
18）Watari I, Oka S, Tanaka S, et al. Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study. BMC Gastroenterol. 2013; 13: 108
|
|
|
|
|
|
19）Hayashi S, Kurata N, Yamaguchi A, et al. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors. J Pharmacol Exp Ther. 2014; 349: 470-9
|
|
|
|
|
|
20）Amagase K, Yoshida Y, Hara D, et al. Prophylactic effect of egualen sodium, a stable azulene derivative, on gastrointestinal damage induced by ischemia/reperfusion, double antiplatelet therapy and loxoprofen in rats. J Physiol Pharmacol. 2013; 64: 65-75
|
|
|
|
|
|
21）Yamamoto A, Itoh T, Nasu R, et al. Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats. World J Gastroenterol. 2014; 20: 2641-52
|
|
|
|
|
|
22）Ueda T, Hokari R, Higashiyama M, et al. Beneficial effect of an omega-6 PUFA-rich diet in non-steroidal anti-inflammatory drug-induced mucosal damage in the murine small intestine. World J Gastroenterol. 2015; 21: 177-86
|
|
|
|
|
|
23）Kume H, Okazaki K, Takahashi T, et al. Protective effect of an immune-modulating diet comprising whey peptides and fermented milk products on indomethacin-induced small-bowel disorders in rats. Clin Nutr. 2014; 33: 1140-6
|
|
|
|
|
|
24）Tuo B, Wen G, Wei J, et al. Estrogen regulation of duodenal bicarbonate secretion and sex-specific protection of human duodenum. Gastroenterology. 2011; 141: 854-63
|
|
|
|
|
|
25）Tuo B, Wen G, Wang X, et al. Estrogen potentiates prostaglandin E(2)-stimulated duodenal mucosal HCO(3)(-) secretion in mice. Am J Physiol Endocrinol Metab. 2012; 303: E111-21
|
|
|
|
|
|
26）Khomenko T, Deng X, Ahluwalia A, et al. STAT3 and importins are novel mediators of early molecular and cellular responses in experimental duodenal ulceration. Dig Dis Sci. 2014; 59: 297-306
|
|
|
|
|
|
27）Guillemot L, Schneider Y, Brun P, et al. Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury. J Cell Sci. 2012; 125: 5005-14
|
|
|
|
|
|
28）Choi KS, Kim EH, Hong H, et al. Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating gamma-glutamylcysteine synthetase. J Gastroenterol Hepatol. 2012; 27 Suppl 3: 13-22
|
|
|
|
|
|
29）岡部治弥，崎村正弘．仮称“非特異性多発性小腸潰瘍症”．胃と腸．1968; 3: 1539-49
|
|
|
|
|
30）Matsumoto T, Kubokura N, Matsui T, et al. Chronic nonspecific multiple ulcer of the small intestine segregates in offspring from consanguinity. J Crohns Colitis. 2011; 5: 559-65
|
|
|
|
|